Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2

Immunotherapy is a new and very promising method of anti-cancer treatment. Unfortunately, not every patient can benefit from this treatment. The Polish drug program determines the selection of patients based on PD-L1 expression and the performance status assessed with the use of Eastern Cooperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Mojsak, Damian, Kuklińska, Beata, Dębczyński, Michał, Mróz, Robert Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063900/
https://www.ncbi.nlm.nih.gov/pubmed/33911982
http://dx.doi.org/10.5114/wo.2021.105031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063900/
https://www.ncbi.nlm.nih.gov/pubmed/33911982
http://dx.doi.org/10.5114/wo.2021.105031

Ejemplares similares